The use of mindfulness-based treatments for individuals with anxiety disorders is as effective as a common antidepressant medication, according to the authors of a recent study.
Psych Congress cochair Charles Raison, MD, discusses the risks that patients face when stopping an antidepressant and possible problems with restarting it.
A joint clinical practice guideline on the management of major depressive disorder was released earlier this year, which included 36 recommendations on screening, monitoring, and treating this condition. ...
The researchers examined the association between a family history of psychiatric disorders and a diagnosis of postpartum depression in mothers, citing little consistency in the area of research.
Researchers examined the relationship between the use of statins and markers of depression vulnerability to better understand the antidepressant potential of these medications.
Poor sleep affects Black individuals more than people of other racial groups. Researchers examined the impact of providing standard cognitive behavioral therapy for insomnia vs culturally tailored CBT-I via...
In this week’s COVID-19 roundup, we discuss the EUA for a breathalyzer test, updated WHO guidelines, drug-drug interactions when treating COVID, and psychiatric disorders after breakthrough infection.
In a recent study, researchers compared the efficacy of a mindfulness-based treatment vs group psychotherapy for patients with chronic pain and misusing opioids.
